Your browser doesn't support javascript.
loading
Results of PD-L1 Analysis of Women Treated with Durvalumab in Advanced Endometrial Carcinoma (PHAEDRA).
Smith, Deborah; Robledo, Kristy P; Yip, Sonia; Cummins, Michelle M; Kok, Peey-Sei; Lee, Yeh Chen; Friedlander, Michael; Baron-Hay, Sally; Shannon, Catherine; Coward, Jermaine; Beale, Philip; Goss, Geraldine; Meniawy, Tarek; Lombard, Janine; Spurdle, Amanda B; Andrews, John; Stockler, Martin R; Mileshkin, Linda; Antill, Yoland.
Afiliação
  • Smith D; Mater Pathology, Mater Research, University of Queensland, Brisbane, QLD 4072, Australia.
  • Robledo KP; National Health and Medical Research Council Clinical Trials Centre, University of Sydney, Camperdown, Sydney, NSW 2050, Australia.
  • Yip S; National Health and Medical Research Council Clinical Trials Centre, University of Sydney, Camperdown, Sydney, NSW 2050, Australia.
  • Cummins MM; National Health and Medical Research Council Clinical Trials Centre, University of Sydney, Camperdown, Sydney, NSW 2050, Australia.
  • Kok PS; National Health and Medical Research Council Clinical Trials Centre, University of Sydney, Camperdown, Sydney, NSW 2050, Australia.
  • Lee YC; National Health and Medical Research Council Clinical Trials Centre, University of Sydney, Camperdown, Sydney, NSW 2050, Australia.
  • Friedlander M; Prince of Wales Clinical School, University of New South Wales and Royal Hospital for Women, Randwick, Sydney, NSW 2031, Australia.
  • Baron-Hay S; Chris O'Brien Lifehouse, Camperdown, Sydney, NSW 2050, Australia.
  • Shannon C; Prince of Wales Clinical School, University of New South Wales and Royal Hospital for Women, Randwick, Sydney, NSW 2031, Australia.
  • Coward J; Royal North Shore Hospital, St Leonards, NSW 2065, Australia.
  • Beale P; Mater Cancer Centre, South Brisbane, QLD 4101, Australia.
  • Goss G; ICON Cancer Centre, South Brisbane, QLD 4101, Australia.
  • Meniawy T; Chris O'Brien Lifehouse, Camperdown, Sydney, NSW 2050, Australia.
  • Lombard J; Monash Medical Centre, Melbourne, VIC 3168, Australia.
  • Spurdle AB; Sir Charles Gairdner Hospital, Perth, WA 6009, Australia.
  • Andrews J; Calvary Mater Newcastle, Newcastle, NSW 2298, Australia.
  • Stockler MR; QIMR Berghofer Medical Research Institute, Herston, QLD 4006, Australia.
  • Mileshkin L; National Health and Medical Research Council Clinical Trials Centre, University of Sydney, Camperdown, Sydney, NSW 2050, Australia.
  • Antill Y; National Health and Medical Research Council Clinical Trials Centre, University of Sydney, Camperdown, Sydney, NSW 2050, Australia.
Cancers (Basel) ; 15(1)2022 Dec 30.
Article em En | MEDLINE | ID: mdl-36612250
Palavras-chave
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Tipo de estudo: Prognostic_studies Idioma: En Revista: Cancers (Basel) Ano de publicação: 2022 Tipo de documento: Article País de afiliação: Austrália
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Tipo de estudo: Prognostic_studies Idioma: En Revista: Cancers (Basel) Ano de publicação: 2022 Tipo de documento: Article País de afiliação: Austrália